top of page

Identify circulating tumor cells with a simple blood test.

Detect the cells before they spread.

The OncoDiscover® CTC Test detects circulating tumor cells in the bloodstream using a simple blood sample—helping reveal whether cancer may be spreading before it becomes visible through conventional methods.

Book a test
od cells

A diagnostic test that is patented globally and approved by DCG(I)

Know more
OncoDiscover hope

Requires just 5ml of blood

The OncoDiscover® CTC Test requires only 5ml of the patient’s blood sample.

Can be done frequently

The OncoDiscover® CTC Test can be done at regular intervals for continuous monitoring and arriving at therapy decisions.

OncoDiscover hope
OncoDiscover hope

No exposure to radiation

The test is conducted on patient’s blood sample at our diagnostic laboratory. Patients don’t have to go through any physically painful and emotionally stressful tests that use radiations.

Convenient. No fasting.

Our registered phlebotomists can collect the blood samples from patient’s home. There are no restrictions with regards to fasting or medication for the blood sample.

OncoDiscover hope

Leading institutions use
the OncoDiscover® CTC Test

OncoDiscover® CTC Test is being widely accepted by the oncology fraternity and is used for monitoring and effective therapy decisions.

Actrec.png
AIIMS_New_Delhi.png
tmh-logo-2021.png
Tata-Memorial-cancer centre.png
Max-Healthcare-Logo.png
HCG-Hospitals.png
apollo_hospital.png
fortis-hospitals-logo-png_seeklogo-214982.png
01 (1)
Screenshot+2022-10-09+at+10.18.10+PM
WhatsApp+Image+2022-06-29+at+8.59.42+AM
_kiranshaw
_drharshvardhan

Fighting cancer.

One cell at a time.

One in a billion cells.

Even a single tumor cell can cause cancer relapse and can lead to metastasis (spread of cancer). OncoDiscover® CTC Test detects, with pinpoint accuracy, those pesky cells whose presence, even a single one of them, leads to the spread of cancer even after the patient’s treatment has been completed and the patient seems to have recovered.

Cost-effective

The OncoDiscover® CTC Test has been developed with a goal of making it affordable and accessible to everyone who is in need of it. It is 50% cheaper than any other test to diagnose cancer cells.

Time Saving

At OncoDiscover® laboratory the diagnostic test are run on the blood samples of the patients. Typically a complete run cycle is completed within a weeks time followed by analysis by scientific experts.

Accurate

The OncoDiscover® CTC Test can identify pesky tumor cells amongst billions of cells in the blood samples from the patients. It is as accuarate as counting one in a billion cells from the blood sample.

Safe

The OncoDiscover® CTC Test is absolutely safe. Only 5 ml of patients blood sample is collected and subject to the diagnostic runs. Patients don’t need to through any other tests including that involving radiations.

Convenient

The OncoDiscover® CTC Test is a simple blood test. Just book the CTC Test online or through a phone call. Our registered phlebotomists can collect the blood samples from patient’s home.

Pain-free

The patient doesn’t have to go through any medical procedure or go through any tissue biopsy. All that it needs is patients blood samples - ensuring its physically and emotionally pain-free for the patient.

GeminiGenerated_Image_nzs47ynzs47ynzs4.png

11000+

Patients Served

450+

Doctors Trust Us

300+

Publications

13+

Years of Excellence

Why choose us?

Our approach is grounded in rigorous research, advanced platforms, and a commitment to meaningful outcomes.

Patented Techologies

Proprietary innovations designed to deliver precision, reliability, and real-world impact.

Regulatory Approved

Regulatory-approved solutions built to meet the highest standards of safety, compliance, and clinical integrity.

Accreditations/ Patents

DCGI
DCG(I) Approved
License No.
MFG/IVD/2019/000031
Intertek
ISO 13485:2016 certified
by INTERTEK;
Certificate No. 0140783
Gobal Bio India
Innovator of the Year 2019
Department of Biotechnology, Government of India
Patent
Patented
International Application No. 
PCT/IB2016/050779

Our
Publications

In collaboration with researchers and thought leaders around the world, OncoDiscover® combines scientific expertise with cutting-edge innovation to advance the frontiers of cancer care. The research behind the technology is supported by 80+ scientific publications presented at leading global forums such as ASCO, AACR, ESMO, ISLB, etc

View all publications
asco-logo-header-desktop-580.png
American_Association_for_Cancer_Research_logo.png
logo-ISLB1.png
ESMO_logo_RGB.png

Latest from Actorius

Explore the latest updates, research perspectives, announcements, and stories shaping our work.

View all updates
ASCO 2026 : Association of circulating tumor cells with PD-L1 expression and clusters in confirmative tumor thrombus in selective solid cancers.

2 June 2026

Read More
ASCO 26: Assessment of circulating tumor cells and clusters expressing PD-L1 in urological cancers

2 June 2026

Read More
ASCO 2026: Comparative enumeration of circulating tumor cells with PD-L1 over expression using anti EpCAM antibody to N-Cadherin in solid cancers

2 June 2026

Read More

OncoDiscover® in Action

Stay updated with our latest events, scientific discussions, collaborations, and milestones that continue to shape the future of cancer research and innovation.

View all events
Meeting with Oncology KOLs in USA | Klaus Pantel , Catherine Alix, Umberto, Ravindra Kolhe
Meeting with KOLs in USA

20 February 2026

Read More
Actorius ISLB 2025 | 1-3 November 2025
ISLB 2025 | 1-3 November 2025

3 November 2025

Read More
Actorius at ESMO 2025
ESMO 2025 | 17–21 October 2025

17 October 2025

Read More
B&W+1.webp

Be informed.
Be a fighter.

Patient Testimonials

Hear directly from patients about their experiences and outcomes with our innovations.

View all testimonials

Sharvari Pantekar

Breast Cancer Survivor

Rupali Gunjikar

Neuro-endocrine Cancer Survivor

OncoDiscover hope

Whats more painful than a cancer relapse? - a cancer relapse not caught in time.

Early detection is half the battle won.

Book a Test

Simply book a CTC Test online or over a phone call and schedule a visit by our registered phlebotomists.

Sample Collection

Upon booking the CTC Test, one of our registered phlebotomists shall visit and collect 5 ml of patient’s blood sample.

Receive Report

A set of diagnostics will be run on the patient’s blood sample and the report shall be provided in 7 working days upon receipt of sample on site.

Book a test

In the News

Explore how OncoDiscover® is making headlines in cancer research and diagnostics.

View all mentions
hindustantimes.png
Startup Mantra: Making cancer detection more accessible
Founded in 2013 by Jayant Khandare and Aravindan Vasudevan, the company has launched its first product, the ‘OncoDiscover Liquid Biopsy Test’, a minimally invasive test which can be performed multiple times requiring 1.5ml blood volume…

August 6, 2022

Read More
bs logo.png
Pune scientists discover tech, first in India, to detect early spread of cancer.
The new "OncoDiscover" technology discovered by a team led by Dr Jayant Khandare not only detects the early spread of cancer but doctors say it can also speed up the cancer detection process…

August 24, 2019

Read More
ET logo.png
Pune scientists develop tech to detect early spread of cancer
The 'OncoDiscover' technology has been approved by the Central Drugs Standard Control Organisation, the national regulatory body for pharmaceuticals and medical  ..…

August 19, 2019

Read More
OncoDiscover Startup Mantra
Actorius Book a test

Remission gives you hope. This test gives you confidence.

OncoDiscover detects circulating tumour cells early, enabling timely decisions, better control, and renewed confidence.

Book a test
bottom of page